Anavex Life Sciences (AVXL) Short-term Investments (2018 - 2019)

Anavex Life Sciences (AVXL) reported Short-term Investments of $15000.0 for Q2 2019, little changed sequentially from $15000.0 in Q1 2019.

Anavex Life Sciences (AVXL) Short-term Investments (2018 - 2019) Analysis & Trends

Anavex Life Sciences (AVXL) has 2 years of Short-term Investments data on file, last reported at $15000.0 in Q2 2019.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Oculis Holding AG	67,583.17 Bn	67,582.89 Bn	-
2	Nanobiotix	1,947.22 Bn	1,947.15 Bn	-
3	Akari Therapeutics	1,132.35 Bn	1,132.35 Bn	-
4	BeOne Medicines	473.21 Bn	468.42 Bn	1.35 Bn
5	Vertex Pharmaceuticals	123.29 Bn	116.04 Bn	2.59 Bn
6	Regeneron Pharmaceuticals	70.05 Bn	61.29 Bn	3.31 Bn
7	Belite Bio	63.09 Bn	63.09 Bn	-
8	Argenx Se	56.63 Bn	51.45 Bn	1.41 Bn
9	Revolution Medicines	37.79 Bn	37.79 Bn	-
10	Anavex Life Sciences	223.02 Mn	91.27 Mn	-

Download Data